Glucotrack, Inc.
GCTK · XNASCIK 1506983fmd_0BZBZVM1DC6HZW0CREW4XC2QGZManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2003 to Jun 30, 2026, 71 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 0 | 0 | – | – | – | – | – | – |
| Net interest income | (0) | 0 | 0 | 0 | – | – | – | – | – | – |
| Research and development | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 9 | 10 |
| Selling, general and administrative | 1 | 8 | 4 | 2 | 0 | 0 | – | 2 | – | – |
| Compensation and benefits | – | – | – | – | 1 | 1 | – | – | – | – |
| Total operating expenses | – | 11 | 7 | 4 | 3 | 4 | 4 | 7 | 15 | 16 |
| Operating income | (6) | 11 | (7) | 4 | (3) | (4) | (4) | (7) | (15) | (16) |
| Interest expense | – | – | – | – | – | – | – | – | 0 | – |
| Other non-operating income (expense) | – | 0 | (0) | (0) | 0 | (0) | (0) | – | (8) | (3) |
| Income before taxes | (5) | (10) | (7) | (4) | (3) | – | – | – | – | – |
| Net income | (5) | 10 | (7) | 4 | (3) | (4) | (4) | (7) | (23) | (19) |
| Net income to common shareholders | (6) | (12) | (40) | (4) | (3) | – | 4 | (8) | (23) | – |